Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
better recovery after physical or mental exertion*
A clinician may recommend: Holding a dose temporarily Slowing titration Adjusting other medications that interact with blood pressure or glucose Evaluating for non-drug causes (eye disease, migraine, neurologic issues) The correct decision depends on the pattern and severity
Indications: FDA approved: Type II diabetes - monotherapy or combination therapy Can be combined as adjunct therapy with other hypoglycemics including metformin, thiazolidinediones, or insulin regimens (Dungan & DeSantis 2015) Because it does not work when your blood sugar is low, it is unlikely to produce dangerous levels of hypoglycemia has been observed in clinical trials (in contrast to GLP-1 incretin mimetics, such as exenatide, which produce moderate weight loss)
GLP-1 medications are a class of drugs used primarily for treating type 2 diabetes and, more recently, for weight management
You may understand the medication well, but if the access plan is confusing, treatment stalls
US$ 20.23
US$ 25.44
US$ 29.50
US$ 28.42
US$ 23.56
